Similar Posts
Quote of the Day
Byadmin“Blindness cuts us off from things, but deafness cuts us off from people.” – Helen Keller (Click to view comments)
Single-Payer Health Care: Love It, Hate It, Love It, Hate It…
ByadminOne reason our healthcare system in the United States is so messed up is that so few Americans understand much about it. For that reason, their attitudes towards various healthcare reform proposals veer left and right depending on how they are asked for their opinions. Here’s great evidence of that phenomenon, as reported by the…
Bait and Switch: The Sneaky Way Your Employer Just Passed Healthcare Costs onto You
ByadminShutterstock If you get health insurance through your job, beware: you might be picking up more of the cost of your medical care than you realize. With increasing frequency, employers are directing their workers to the kind of high deductible, high out-of-pocket insurance plans that leave workers financially responsible for a surprising portion of their…
Making Mammograms Automatic – Unintended Consequences Of A Behavioral Economic Intervention
Byadmin2The experiment was simple. A group of behaviorally-minded researchers tested whether patients are more likely to receive mammograms when those tests are automatically scheduled (meaning they can opt out if they want) versus when they have to opt in for the tests. Automatic scheduling should have increased mammograms. It didn’t. In one respect, it even…
Party First, Ideology Later
ByadminWe think of political parties as being ideological homes. If you embrace conservative ideas, you gravitate to the Republican party, and so on. But probably just as often, people have party homes (“My dad was a Dem, and so am I”), in which whatever the party embraces magically fits their ideology. Consider the following picture…
Debate over New FDA Commissioner
ByadminIn a previous post, I argued in favor of Rob Califf as FDA Commissioner. Here is an article from the Duke Chronicle, exploring more of this important debate. Dr. Robert Califf, former vice chancellor of clinical and translational research, may soon be taking helm of the U.S. Food and Drug Administration, but not without resistance from organizations…